坚果替代碳水化合物对糖尿病饮食的影响:随机对照试验再分析
该研究对一项因未校正重复测量而被撤稿的随机对照试验进行再分析,纳入117例2型糖尿病患者,比较全剂量坚果、全剂量松饼及半剂量坚果饮食3个月对HbA1c及心血管风险因素的影响。结果显示,与全剂量松饼饮食相比,全剂量坚果饮食使HbA1c降低2.0 mmol/mol(95%CI -3.8, -0.3 mmol/mol)(-0.19% [95%CI -0.35%, -0.02%]),p=0.026,并改善多项血脂指标。
要点
- 全剂量坚果饮食(中位摄入75 g/天)较全剂量松饼饮食降低HbA1c 2.0 mmol/mol(p=0.026)。
- 全剂量坚果饮食还显著降低LDL颗粒直径<255埃的胆固醇和载脂蛋白B。
- 按剂量反应预测,全剂量坚果饮食可降低HbA1c、胆固醇、LDL胆固醇、非HDL胆固醇、载脂蛋白B及LDL-c<255Å。
核心结论
- 以坚果替代碳水化合物摄入可改善2型糖尿病患者的血糖控制和血脂风险因素。
研究设计与样本
- 平行设计随机对照试验再分析,纳入117例服用口服降糖药且HbA1c在47.5至63.9 mmol/mol(6.5-8.0%)之间的男性及绝经后女性2型糖尿病患者,按性别和基线HbA1c分层后随机分为三组饮食干预3个月。
主要发现
- 共108例参与者有干预后数据可供分析(全剂量坚果组n=40;全剂量松饼组n=35;半剂量坚果组n=33)。
- 与全剂量松饼饮食相比,全剂量坚果饮食提供的单不饱和脂肪来源总能量摄入高9.2%(95%CI 7.1, 11.3)。
- 全剂量坚果饮食(中位摄入量75 g/天)较全剂量松饼饮食降低HbA1c 2.0 mmol/mol(95%CI -3.8, -0.3 mmol/mol)(-0.19% [95%CI -0.35%, -0.02%]),p=0.026。
- 全剂量坚果饮食较全剂量松饼饮食显著降低LDL颗粒直径<255埃的估计胆固醇水平(LDL-c<255Å)和载脂蛋白B。
- 按剂量反应预测,全剂量坚果饮食可降低HbA1c(-2.0 mmol/mol [-0.18%];p=0.044)、胆固醇(-0.25 mmol/l;p=0.022)、LDL胆固醇(-0.23 mmol/l;p=0.019)、非HDL胆固醇(-0.26 mmol/l;p=0.020)、载脂蛋白B(-0.06 g/l,p=0.013)及LDL-c<255Å(-0.42 mmol/l;p<0.001)。
关键数值与推荐
- 全剂量坚果饮食:每8.4 MJ(2000 kcal)能量中2.0 MJ(477 kcal)由混合坚果提供(75 g/天)。
- 全剂量松饼饮食:每8.4 MJ(2000 kcal)能量中1.97 MJ(471 kcal)由三个全麦松饼提供(188 g/天),蛋白质含量与坚果相似,碳水化合物来源能量与坚果中单不饱和脂肪酸来源能量相同。
- 半剂量坚果饮食:每8.4 MJ(2000 kcal)能量中1.98 MJ(474 kcal)由坚果和松饼各半份提供。
- 主要结局为HbA1c变化。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: In line with current advice, we assessed the effect of replacing carbohydrate consumption with mixed nut consumption, as a source of unsaturated fat, on cardiovascular risk factors and HbA1c in type 2 diabetes. The data presented here are from a paper that was retracted at the authors' request ( https://doi.org/10.2337/dc16-rt02 ) owing to lack of adjustment for repeated measures in the same individual. Our aim, therefore, was to fix the error and add new complementary data of interest, including information on clotting factors and LDL particle size. METHODS: A total of 117 men and postmenopausal women with type 2 diabetes who were taking oral glucose-lowering agents and with HbA1c between 47.5 and 63.9 mmol/mol (6.5-8.0%) were randomised after stratification by sex and baseline HbA1c in a parallel design to one of three diets for 3 months: (1) 'full-dose nut diet' (n = 40): a diet with 2.0 MJ (477 kcal) per 8.4 MJ (2000 kcal) energy provided as mixed nuts (75 g/day); (2) 'full-dose muffin diet' (n = 39): a diet with 1.97 MJ (471 kcal) per 8.4 MJ (2000 kcal) energy provided as three whole-wheat muffins (188 g/day), with a similar protein content to the nuts, and the same carbohydrate-derived energy content as the monounsaturated fatty acid-derived energy content in the nuts; or (3) 'half-dose nut diet' (n = 38): a diet with 1.98 MJ (474 kcal) per 8.4 MJ (2000 kcal) energy provided as half portions of both the nuts and muffins. The primary outcome was change in HbA1c. The study was carried out in a hospital clinical research centre and concluded in 2008. Only the statistician, study physicians and analytical technicians could be blinded to the group assessment. RESULTS: A total of 108 participants had post-intervention data available for analysis (full-dose nut group, n = 40; full-dose muffin group, n = 35; half-dose nut group, n = 33). Compared with the full-dose muffin diet, the full-dose nut diet provided 9.2% (95% CI 7.1, 11.3) greater total energy intake from monounsaturated fat. The full-dose nut diet (median intake, 75 g/day) also reduced HbA1c compared with the full-dose muffin diet by -2.0 mmol/mol (95% CI -3.8, -0.3 mmol/mol) (-0.19% [95% CI -0.35%, -0.02%]), (p = 0.026). Estimated cholesterol levels in LDL particles with a diameter <255 ångström [LDL-c<255Å]) and apolipoprotein B were also significantly decreased after the full-dose nut diet compared with the full-dose muffin diet. According to the dose response, the full-dose nut diet is predicted to reduce HbA1c (-2.0 mmol/mol [-0.18%]; p = 0.044), cholesterol (-0.25 mmol/l; p = 0.022), LDL-cholesterol (-0.23 mmol/l; p = 0.019), non-HDL-cholesterol (-0.26 mmol/l; p = 0.020), apolipoprotein B (-0.06 g/l, p = 0.013) and LDL-c<255Å (-0.42 mmol/l; p < 0.001). No serious study-related adverse events occurred, but one participant on the half-dose nut diet was hospitalised for atrial fibrillation after shovelling snow. CONCLUSIONS/INTERPRETATION: Nut intake as a replacement for carbohydrate consumption improves glycaemic control and lipid risk factors in individuals with type 2 diabetes. TRIAL REGISTRATION: ClinicalTrials.gov NCT00410722 FUNDING: The study was funded by the International Tree Nut Council Nutrition Research and Education Foundation, the Peanut Institute, Loblaw Companies and the Canada Research Chairs Program of the Government of Canada.
引用
- Jenkins DJA, Kendall CWC, Lamarche B, et al. Nuts as a replacement for carbohydrates in the diabetic diet: a reanalysis of a randomised controlled trial. Diabetologia. 2018. PMID: 29789878. doi:10.1007/s00125-018-4628-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。